These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. When are two stents needed? Which technique is the best? How to perform? Latib A; Moussa I; Sheiban I; Colombo A EuroIntervention; 2010 Dec; 6 Suppl J():J81-7. PubMed ID: 21930497 [No Abstract] [Full Text] [Related]
5. Assimilating the current clinical data of fully bioabsorbable stents. Di Mario C; Borgia F EuroIntervention; 2009 Dec; 5 Suppl F():F103-8. PubMed ID: 22100669 [No Abstract] [Full Text] [Related]
6. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy. Wykrzykowska JJ; Onuma Y; Serruys PW EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680 [No Abstract] [Full Text] [Related]
8. Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis. Mangiameli A; Fajadet J; Dumonteil N Int J Cardiovasc Imaging; 2017 Jan; 33(1):1-3. PubMed ID: 27562758 [No Abstract] [Full Text] [Related]
9. Device selection for percutaneous coronary intervention: The case is still open. Lemos PA Catheter Cardiovasc Interv; 2009 Mar; 73(4):466. PubMed ID: 19235235 [No Abstract] [Full Text] [Related]
11. Vessel healing: checking in-vivo results for better treatment. Manfrini O J Cardiovasc Med (Hagerstown); 2011 May; 12(5):311-3. PubMed ID: 21451333 [No Abstract] [Full Text] [Related]
12. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview. Yan J; Bhat VD EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682 [No Abstract] [Full Text] [Related]
13. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation. Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682 [TBL] [Abstract][Full Text] [Related]
14. The Petal dedicated bifurcation stent. Ormiston JA; De Vroey F; Webster MW; Kandzari DE EuroIntervention; 2010 Dec; 6 Suppl J():J139-42. PubMed ID: 21930479 [No Abstract] [Full Text] [Related]
15. Very late scaffold thrombosis after bioresorbable scaffold implantation: an unexpected new enemy on the horizon… or just a false alarm? Collet C; Serruys PW EuroIntervention; 2016 Oct; 12(9):1077-1079. PubMed ID: 27753593 [No Abstract] [Full Text] [Related]
16. The bioabsorption process: tissue and cellular mechanisms and outcomes. Vorpahl M; Finn AV; Nakano M; Virmani R EuroIntervention; 2009 Dec; 5 Suppl F():F28-35. PubMed ID: 22100673 [No Abstract] [Full Text] [Related]
17. The AXXESS™ self-expanding biolimus A9™ eluting stent system for coronary bifurcation lesions. Dubois CL; Wijns W EuroIntervention; 2010 Dec; 6 Suppl J():J130-4. PubMed ID: 21930477 [No Abstract] [Full Text] [Related]
18. Let it be, let it be. Butman SM Catheter Cardiovasc Interv; 2009 Jun; 73(7):898. PubMed ID: 19455656 [No Abstract] [Full Text] [Related]
19. The Nile concept. Fajadet J EuroIntervention; 2010 Dec; 6 Suppl J():J135-8. PubMed ID: 21930478 [No Abstract] [Full Text] [Related]
20. A case of true left main bifurcation treated with bioresorbable everolimus-eluting stent v-stenting. Sato K; Latib A; Panoulas VF; Naganuma T; Miyazaki T; Colombo A JACC Cardiovasc Interv; 2014 Aug; 7(8):e103-4. PubMed ID: 25086841 [No Abstract] [Full Text] [Related] [Next] [New Search]